⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 10, 2026

Depakine Chronosphere 50 mg Retardgranulat in Beuteln 50 mg (Retardgranulat)

📷 Wikipedia: Valproate · Source
Depakine Chronosphere 50 mg Retardgranulat in Beuteln 50 mg (Retardgranulat)
📷 Wikipedia: Valproate · Source
Parallel export ban in effect for Depakine Chronosphere 50 mg Retardgranulat in sachets. Supply is limited due to manufacturing capacity shortages. Affected packs: boxes of 30 sachets, available in limited supply since March 10, 2026, with restocking expected September 30, 2026.
⚠️
Shortage ongoing
NATRIUM VALPROAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a medicine called Depakine Chronosphere. It is used to treat epilepsy and other conditions.

What's happening? There is a shortage of this medicine. Supplies are limited because of production problems.

Does this affect me? If you take this medicine, you may have trouble getting it. Check with your pharmacist.

What should I do? Do not stop taking your medicine without talking to your doctor or pharmacist first.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
NATRIUM VALPROAT VALPROINSÄURE
Agency-published detail

🚫 Parallel export ban active · ATC: N03AG01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sanofi-Aventis GmbH, Turm A, 29. OG, Wienerbergstraße 11, 1100 Wien, Österreich · Affected packs: 30 Stück Schachtel, Beutel [eingeschränkt verfügbar, since 2026-03-10, resupply 2026-09-30]

First published
March 10, 2026
Last refreshed by us
1 week ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT 2 months ago

Depakine Chronosphere 500 mg Retardgranulat in Beuteln 500 mg (Retardgranulat)

Parallel export of Depakine Chronosphere 500 mg Retardgranulat in sachets is banned due to limited production capacity.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Depakine Chronosphere 50 mg Retardgranulat in Beuteln 50 mg (Retardgranulat). Parallel export ban in effect for Depakine Chronosphere 50 mg Retardgranulat in sachets. Supply is limited due to manufacturing capacity shortages. Affected packs: boxes of 30 sachets, available in limited supply since March 10, 2026, with restocking expected September 30, 2026.
▸ When was this alert issued?
This alert was issued on March 10, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.